CCCC — C4 THERAPEUTICS INC

Ownership history in ALGERT GLOBAL LLC  ·  4 quarters on record

This page tracks every 13F SEC filing in which ALGERT GLOBAL LLC reported a position in C4 THERAPEUTICS INC (CCCC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2023 Q2)
Avg. % of fund
0.01%
First filed
2023 Q2
Last filed
2025 Q3
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 106,300 +78,340 +280.2% 0.00% $236K $2.22
2023 Q4 REDUCED 27,960 -23,800 -46.0% 0.01% $158K $5.65
2023 Q3 REDUCED 51,760 -7,310 -12.4% 0.00% $96K $1.86
2023 Q2 INITIATED 59,070 — — 0.01% $162K $2.75
% of Fund (quarterly)    CCCC price (monthly, adj. close)

Other funds also holding CCCC

As of 2025 Q4 — sorted by position size

Lynx1 Capital Management LP 3Y 2.74% Bain Capital Life Sciences Investors, LLC 3Y 7Y 1.05% SILVERARC CAPITAL MANAGEMENT, LLC 3Y 0.53% Soleus Capital Management, L.P. 3Y 0.27% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 0.16% INTREPID FAMILY OFFICE LLC 3Y 0.09% Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group 0.08% ORBIMED ADVISORS LLC 3Y 7Y 0.05% WASATCH ADVISORS LP 3Y 7Y 0.05% 683 Capital Management, LLC 3Y 7Y 0.03%
← Back to ALGERT GLOBAL LLC Holdings